We apologise for any inconvenience caused with the sudden change back from the Sole Supply and Tender Winning product – ISOTANE (Sole Supply has been deferred until further notice) to the previously sole supply product – ORATANE (Delisting has been deferred until further notice)
We have been caught out and are currently working to rectify the situation.
Isotretinoin Sole Supply delay
The Sole Subsidised Supply of Isotane 10 and Isotane 20 brands of isotretinoin cap 10mg and 20mg will be delayed until a date yet to be determined. The Oratane brand will remain fully funded until further notification. Oratane 10mg and 20mg will not be delisted from 1 February 2016 as previously notified.